Bio-Works Technologies AB

Equities

BIOWKS

SE0007387089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:17:43 2024-05-06 am EDT			5-day change	1st Jan Change
2.8 ^SEK	-1.75%		-4.76%	-60.56%

Apr. 25	Bio-Works Technologies AB Announces Johan Sedihn Declines Re-Election as Member of Board	CI
Apr. 16	Bio-Works Technologies AB Confirms New Order from Indian Biotherapeutic Manufacturer Worth SEK 3.1 Million	CI

Bio-Works Technologies AB Confirms New Order from Indian Biotherapeutic Manufacturer Worth SEK 3.1 Million

April 16, 2024 at 08:41 am EDT

Bio-Works Technologies AB has confirmed a production-scale order worth SEK 3.1 million to an Indian manufacturer of bio-therapeutics. This order is a repeat order from a customer which first started using Bio-Works' products in 2021. The company that placed the order is a bio-therapeutics manufacturer with launched products and development projects in the areas of plasma proteins, biosimilars, novel proteins and stem cells therapies.

They employee over 1,000 people globally. The order is confirmed for delivery in the second quarter.

Latest news about Bio-Works Technologies AB

Bio-Works Technologies AB Announces Johan Sedihn Declines Re-Election as Member of Board	Apr. 25	CI
Bio-Works Technologies AB Confirms New Order from Indian Biotherapeutic Manufacturer Worth SEK 3.1 Million	Apr. 16	CI
Bio-Works Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 19	CI
Bio-Works Expands Product Range with Introduction of WorkBeads 40 Butyl SH	Feb. 16	CI
Bio-Works Technologies Books SEK1.9 Million Workbeads Resin Order	Jan. 18	MT
Bio-Works Receives Repeat Order for Workbeads Resin	Jan. 18	CI
Bio-Works Technologies AB's Nomination Committee for the 2024 Annual General Meeting	Nov. 09	CI
Bio-Works Technologies Books Order from American Gene Therapy Products Manufacturer	23-10-25	MT
Bio-Works Secures SEK 0.8 Million Order for Gene Therapy Manufacturing	23-10-25	CI
Bio-Works Technologies AB Reports Sales Results for the Third Quarter of 2023	23-10-09	CI
Sweden's Bio-Works Technologies Names CFO	23-09-06	MT
Bio-Works Technologies AB Announces Appointment of Arne Hauge as Chief Financial Officer	23-09-06	CI
Bio-Works Technologies AB Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Bio-Works Technologies to Reduce Workforce Under Restructuring Program; Shares Down 10%	23-05-29	MT
Bio-Works Implements Restructuring Program	23-05-29	CI
Patrick Van De Velde Declines Re-Election as Director At Bio-Works Technologies	23-02-22	CI
Bio-Works Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-17	CI
Sweden's Bio-Works Technologies Books SEK3.4 Million GoBio Order	23-01-20	MT
Bio-Works Confirms New Order for Gobio Prepacked Columns to the American Market	23-01-20	CI
Bio-Works Technologies Enters Finnish Distribution Deal With Biotop	23-01-11	MT
Bio-Works Signs Distributor Agreement with Biotop Oy for the Finnish Market	23-01-11	CI
Bio-Works Technologies AB Wins EU Grant for Development of Environmentally-Friendly Purification of Biotherapeutics	22-12-20	CI
Bio-Works Technologies AB Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Bio-Works Technologies AB Launches GoBio, New Product Line Saves Time in Biotherapeutic Production	22-06-30	CI
Bio-Works Technologies AB Reports Sales Results for the First Quarter of 2022	22-04-21	CI

Chart Bio-Works Technologies AB

Duration

Period

More charts

Company Profile

Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-15 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BIO-WORKS TECHNOLOGIES AB	-60.56%	10.28M
ABBOTT LABORATORIES	-4.02%	184B
MEDTRONIC PLC	-0.75%	108B
BECTON, DICKINSON AND COMPANY	-2.97%	67.82B
DEXCOM, INC.	+4.48%	51.05B
CENCORA, INC.	+9.09%	44.67B
HOYA CORPORATION	+3.40%	41.78B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.12%	26.78B
WEST PHARMACEUTICAL SERVICES, INC.	+4.10%	26.59B
TERUMO CORPORATION	+15.23%	25.86B

Other Medical Equipment, Supplies & Distribution